Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22817570 | 0.93 | GGPS1 (0.31) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL678643 | 0.82 | SIGMAR1 (0.38) | OPRM1CACNA2D1SIGMAR1 | |
| SCHEMBL20675493 | 0.79 | ALDH1A1 (0.37) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL19705235 | 0.79 | CHRM2 (0.45) | — | |
| SCHEMBL19478585 | 0.79 | CACNA2D1 (0.33) | CACNA2D1SIGMAR1 | |
| SCHEMBL20664136 | 0.78 | CHRM2 (0.32) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL22353248 | 0.77 | — | — | |
| SCHEMBL13649903 | 0.77 | CHRM2 (0.36) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL17225210 | 0.77 | CHRM2 (0.39) | GGPS1FDPSAGTR1OPRM1PDE3A | |
| SCHEMBL21937936 | 0.76 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170327448-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327448-A1 | METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS | GK, MSMO1, DGKG | GGPS1 342/4885FDPS 1520/4885AGTR1 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.